Continuity Biosciences Invests in PinPrint, Inc., Expanding into Aesthetic and Cosmetic Drug Delivery

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

ContinuityBiosciences

More Like This

PR Newswire associated0

Continuity Biosciences Launches to Enable Breakthrough Therapies with Innovative Delivery Technologies

PR Newswire associated0

Continuity Biosciences Appoints Josephine Torrente and Joseph DeSimone, PhD to Board of Directors

PR Newswire associated0

NanoPass Technologies Expands Product Portfolio to Advance Intradermal Delivery

PR Newswire associated0

Continuity Biosciences Acquires Focal Medical to Advance Targeted Drug Delivery for Pancreatic Cancer

Lindy Biosciences Enters Licensing and Collaboration Agreement With Novartis for Multi-target Drug Delivery Innovation

PR Newswire associated0

Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study

PR Newswire associated0

Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

PR Newswire associated0

Crown Aesthetics Announces Groundbreaking Study on Skin Microbiome-Optimized BIOJUVE™ Regimen